For Hometown news
PORT ST. LUCIE -- Libby Handel was named director of business development at Torrey Pines Institute for Molecular Studies where she will be responsible for commercializing research and technologies, creating and managing spin-off companies and directing technology licensing activities.
"We are extremely pleased to have Libby join our team," said Richard Houghten, president of Torrey Pines Institute. "Her broad scientific and business experience, along with her proven ability to produce results, will be essential to Torrey Pines as we commercialize our technologies."
Ms. Handel has more than 15 years of life-science experience, including at the universities of Illinois and Colorado, The Brigham and Women's Hospital and recently at Palm Beach State College where she served as director of biotechnology programs and director of the Banner Center for Life Sciences.
"I am honored to serve the scientists at Torrey Pines Institute by translating their innovative research discoveries into commercial products that can impact human health," said Ms. Handel.
Torrey Pines Institute for Molecular Studies is a 501(c)(3) research center dedicated to conducting basic research to advance the understanding of human disease and improve human health.
Scientists conduct research in fields associated with a wide variety of major medical conditions, including multiple sclerosis, cancer, heart disease, types I and II diabetes, macular degeneration, pain management, Alzheimer's, inflammatory disorders, AIDS and other infectious diseases, regenerative medicine, obesity, transplant rejection, muscle wasting syndrome, rheumatoid arthritis and new methods for drug discovery.